CONMED Corporation Stock News

PDCO vs. CNMD: Which Stock Is the Better Value Option?

New Jersey, United States,- Verified Market Research has recently published a research report titled, Myomectomy Market Size, and Forecast 2021-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. Primary and secondary research methodologies have been used to formulate this

CONMED Co. (NYSE:CNMD) declared a quarterly dividend on Monday, November 29th, RTT News reports. Stockholders of record on Wednesday, December 15th will be given a dividend of 0.20 per share on Wednesday, January 5th. This represents a $0.80 annualized dividend and a dividend yield of 0.58%. The ex-dividend date of this dividend is Tuesday, December […]

The Gastrointestinal Devices Market Report provides detailed analysis of Growth Factors of the market as well as it gives an analysis of the Market size, Latest trends, SWOT Analysis by Regions and Forecasted market research data until 2027. The Gastrointestinal

The Lacrimal Device Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an

CONMED (NYSE:CNMD) and Yubo International Biotech (OTCMKTS:YBGJ) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings. Volatility and Risk CONMED has a beta of 1.56, indicating that its stock price is 56% []

CONMED (NYSE:CNMD) and Second Sight Medical Products (NASDAQ:EYES) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, dividends, valuation and earnings. Analyst Recommendations This is a summary of recent ratings for CONMED and Second Sight Medical []

The Specimen Retrieval and Foreign-Body Removal Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research

Brokerages expect CONMED Co. (NYSE:CNMD) to report earnings per share of $1.06 for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for CONMEDs earnings. The highest EPS estimate is $1.07 and the lowest is $1.05. CONMED reported earnings of $0.84 per share during the same quarter last year, which would suggest []

Suture Anchors Market: Introduction According to the report, the global suture anchors market was valued at US$ 0.6 Bn in 2020 and is projected to expand at a CAGR of ~5% from 2021 to 2031. Suture anchors are designed to heal

Wall Street brokerages expect CONMED Co. (NYSE:CNMD) to report earnings per share (EPS) of $1.06 for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for CONMEDs earnings. The lowest EPS estimate is $1.05 and the highest is $1.07. CONMED posted earnings of $0.84 per share in the same quarter []

Overview Arthroscopic and imaging devices, arthroscopic resection systems, arthroscopic fluid control systems, arthroscopic implants, and arthroscopy RF systems are all examples of arthroscopy products that are included in procedures including small joint arthroscopy, shoulder arthroscopy, elbow arthroscopy, knee arthroscopy, and hip

Accurate market intelligence can be obtained with the help of SWOT analysis provided in the first class Surgical visualization products market report that aid businesses identify opportunities as well as both internal and external influences. With the wonderful secondary research

Parametric Portfolio Associates LLC lifted its position in shares of CONMED Co. (NYSE:CNMD) by 10.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 88,862 shares of the companys stock after buying an additional 8,279 shares during the period. Parametric Portfolio Associates LLC owned []

Fc Global Realty (OTCMKTS:FCRE) and CONMED (NYSE:CNMD) are both computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends. Analyst Recommendations This is a summary of current recommendations and price targets for Fc []